5 assets in Constipation Disorder

Therapeutic assets addressing Constipation Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Polyethylene Glycol 3350 Constipation Disorder	Chad R. Tracy	P4	BB (65)
Tenapanor Constipation Disorder	Massachusetts General Hospital	P3	B (58)
Pyridostigmine Constipation Disorder	University of Vermont Medical Center	P2	CCC (53)
Misoprostol Constipation Disorder	Montefiore Medical Center	Early P1	C (39)
Maralixibat Constipation Disorder	Children's Hospital Los Angeles	P2/3	NR ()